Skip to main content
. 2018 Apr 1;2018:5832460. doi: 10.1155/2018/5832460

Figure 7.

Figure 7

Survival and recovery of CB-MSCs after treatment with 40 pg/mL of human recombinant IL-6 protein and AcS. Survival rates (a) were calculated by normalizing to the cell numbers before AcS. Ratios of apoptotic, necrotic, and live cells (b) were quantified by flow cytometry. Cell numbers (c) and metabolic activity (d) were measured one day before AcS. Measurements were repeated 4 hours after AcS and at days 1, 3, and 5 after AcS.